<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors studied 16 consecutive cases of <z:hpo ids='HP_0005305'>cerebral venous thrombosis</z:hpo> (CVT) </plain></SENT>
<SENT sid="1" pm="."><plain>Clinical outcome was good or excellent in 14 patients </plain></SENT>
<SENT sid="2" pm="."><plain>Comprehensive hypercoagulable screening was done at least 3 months after the <z:hpo ids='HP_0003674'>onset</z:hpo> of CVT, including evaluation of genetic <z:e sem="disease" ids="C0005779" disease_type="Disease or Syndrome" abbrv="">coagulation disorders</z:e> and plasma levels of <z:chebi fb="0" ids="17230">homocysteine</z:chebi> and factor VIII </plain></SENT>
<SENT sid="3" pm="."><plain>This screening was positive in 12 patients (75%) </plain></SENT>
<SENT sid="4" pm="."><plain>An acquired prothrombotic factor was identified in 9 of these 12 patients </plain></SENT>
<SENT sid="5" pm="."><plain>Elevation of factor VIII plasma level was the most common <z:e sem="disease" ids="C0005779" disease_type="Disease or Syndrome" abbrv="">coagulation disorder</z:e> (8 patients) </plain></SENT>
</text></document>